There are approximately 1000 research groups on the #NIH campuses, including Steve Rosenberg's research group, which develops groundbreaking T-cell therapies for cancer.
Effectively all of those groups were suddenly prohibited from buying any (!) supplies last year.
That is on the leadership.
Mark Histed
BHATTACHARYA: I do not believe patients' care was disrupted. If there were disruptions, it's the responsibility of the researchers, not the NHS
HASSAN: That is an unacceptable and outrageous response. You can make an edict - 'Don't disrupt care!' - but that can be a very complicated thing